Home / News / India News / Article / India examining strategy: Centre on Pfizer COVID-19 vaccine constraints

India examining strategy: Centre on Pfizer COVID-19 vaccine constraints

The NITI Aayog member further said that there are five COVID-19 vaccine candidates under various stages of clinical trials in India of which two are in the third phase

Listen to this article :
This picture has been used for representational purposes

This picture has been used for representational purposes

The Union Health Ministry on Tuesday said that the central government is examining all possibilities to extend cold chain facilities in case Pfizer's COVID-19 vaccine needs to be procured. Responding to a query on vaccine storage at low temperature, Dr VK Paul, NITI Aayog member (Health) said it would be a huge challenge for any country to maintain cold chain facility at a lower temperature of -70 degree or -80 degree celsius and scale-up vaccine procurement. "However, knowing all the circumstances, we are examining how to scale up vaccine storage facilities."

"We are keeping a close watch on the development of these vaccines and we are also aware of the fact that we won't be able to get a large number of doses of this vaccine required for our population. In case, union government procures it, all necessary arrangements will be made parallelly," said Dr Paul at a media briefing on COVID-19 update in India.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
Gaikwad Patil to campaign for NCP candidate in MLC polls

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement